Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs

MLA

Ademola C. Famurewa, et al. “Repurposing FDA-Approved Drugs against the Toxicity of Platinum-Based Anticancer Drugs.” Life Sciences, vol. 305, Sept. 2022, p. 120789. EBSCOhost, https://doi.org/10.1016/j.lfs.2022.120789.

APA

Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Aarthi Sukumar, Reshma Murali, Kaviyarasi Renu, Balachandar Vellingiri, Abhijit Dey, & Abilash Valsala Gopalakrishnan. (2022). Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs. Life Sciences, 305, 120789. https://doi.org/10.1016/j.lfs.2022.120789

Chicago

Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Aarthi Sukumar, Reshma Murali, Kaviyarasi Renu, Balachandar Vellingiri, Abhijit Dey, and Abilash Valsala Gopalakrishnan. 2022. “Repurposing FDA-Approved Drugs against the Toxicity of Platinum-Based Anticancer Drugs.” Life Sciences 305 (September): 120789. doi:10.1016/j.lfs.2022.120789.